pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 1,831 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health131
viewlistcards
  • Marketed
    (atezolizumab + hyaluronidase (human recombinant))
    Tecentriq Hybreza ((atezolizumab + hyaluronidase-tqjs (human recombinant)))
    Hepatocellular Carcinoma Genentech Inc5 cat
  • Marketed
    (hyaluronidase (recombinant, human) + nivolumab)
    Opdivo Qvantig ((hyaluronidase-nvhy (recombinant, human) + nivolumab))
    Adenocarcinoma Of The Gastroesophageal Junction Bristol-Myers Squibb Co5 cat
  • Marketed
    CLADRIBINE
    CLADRIBINE
    Relapsing Remitting Multiple Sclerosis (RRMS) EMD Serono Inc1 cat
← prev
page 5 of 62
next →
Pain89
Neurology1
Marketed
enfortumab vedotin
Padcev (enfortumab vedotin-ejfv)
Muscle Invasive Bladder Cancer (MIBC)
Astellas Pharma Inc
12 cat
  • Marketed
    FULVESTRANT
    FULVESTRANT
    Hormone Sensitive Breast Cancer Eagle Pharmaceuticals Inc4 cat
  • Marketed
    cosibelimab
    Unloxcyt (cosibelimab-ipdl)
    Cutaneous Squamous Cell Carcinoma (cSCC) Checkpoint Therapeutics Inc2 cat
  • Marketed
    selpercatinib
    Retevmo (selpercatinib)
    Anaplastic Thyroid Cancer Eli Lilly and Co19 cat
  • Marketed
    tarlatamab
    Imdelltra (tarlatamab-dlle)
    Small-Cell Lung Cancer$AMGN AMGEN INC2 cat
  • Marketed
    sevabertinib
    Hyrnuo (sevabertinib)
    Non-Small Cell Lung Cancer Bayer AG1 cat
  • Marketed
    alitretinoin
    Panretin (alitretinoin)
    Kaposi Sarcoma Galephar Pharmaceutical Research Inc5 cat
  • Marketed
    pertuzumab biosimilar
    Poherdy (pertuzumab-dpzb)
    Human Epidermal Growth Factor Receptor 2 Positive Breast… EirGenix Inc1 cat
  • Marketed
    tisotumab vedotin
    Tivdak (tisotumab vedotin-tftv)
    Bladder Cancer Genmab AS4 cat
  • Marketed
    amivantamab
    Rybrevant (amivantamab-vmjw)
    Non-Small Cell Lung Cancer Janssen Biotech Inc11 cat
  • Marketed
    lazertinib mesylate
    Lazcluze (lazertinib mesylate)
    Non-Small Cell Lung Cancer$JNJ JOHNSON & JOHNSON3 cat
  • Marketed
    NELARABINE
    NELARABINE
    no indication$AMRX Amneal Pharmaceuticals, Inc.2 cat
  • Marketed
    methylprednisolone sodium succinate
    Methylprednisolone Sodium Succinate
    Drug Hypersensitivity Reactions Sagent Pharmaceuticals Inc48 cat
  • Marketed
    pentostatin
    Pentostatin
    Hairy Cell Leukemia Hikma Pharmaceuticals USA Inc12 cat
  • Marketed
    axitinib SR
    AXPAXLI (axitinib)
    Wet (Neovascular / Exudative) Macular Degeneration$OCUL OCULAR THERAPEUTIX, INC1 cat
  • Marketed
    denosumab biosimilar
    Jubereq (denosumab-dssb)
    Post Menopausal Osteoporosis Luye Pharma Group Ltd2 cat
  • Marketed
    glofitamab
    Columvi (glofitamab-gxbm)
    Mantle Cell Lymphoma F. Hoffmann-La Roche Ltd3 cat
  • Marketed
    LOMUSTINE
    LOMUSTINE
    Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) Carnegie Pharmaceuticals LLC1 cat
  • Marketed
    ANASTROZOLE
    ANASTROZOLE
    Hormone Sensitive Breast Cancer Stason Pharmaceuticals Inc11 cat
  • Marketed
    revumenib citrate
    Revuforj (revumenib citrate)
    Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leuk…$SNDX Syndax Pharmaceuticals Inc2 cat
  • Marketed
    belantamab mafodotin
    Blenrep (belantamab mafodotin-blmf)
    Refractory Multiple Myeloma GlaxoSmithKline LLC1 cat
  • Marketed
    erdafitinib
    Balversa (erdafitinib)
    Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial B…$JNJ JOHNSON & JOHNSON11 cat
  • Marketed
    futibatinib
    Lytgobi (futibatinib)
    Bile Duct Cancer (Cholangiocarcinoma) Taiho Oncology Inc3 cat
  • Marketed
    relugolix
    Orgovyx (relugolix)
    Prostate Cancer Sumitomo Pharma America Inc4 cat
  • Marketed
    EXEMESTANE
    EXEMESTANE
    Metastatic Breast Cancer$PFE PFIZER INC8 cat
  • Marketed
    LETROZOLE
    LETROZOLE
    Breast Cancer Yiling Pharmaceutical Ltd9 cat
  • Marketed
    IFOSFAMIDE
    IFOSFAMIDE
    Germinomatous (Seminomatous) Germ Cell Tumors Baxter Healthcare Corp4 cat